Chongqing Pharscin Pharmaceutical (002907.SZ) has completed the domestic production drug registration for three products.
Huarson Pharmaceuticals (002907.SZ) announcement, the company recently obtained information from the website of the China Food and Drug Administration that the company's...
Chongqing Pharscin Pharmaceutical (002907.SZ) announced that the company recently obtained information from the website of the National Medical Products Administration that three of the company's products have completed the domestic production drug filing (application for drug instructions suitability for the elderly) and the filing information has been publicly posted on the website of the National Medical Products Administration. The related products are: Ba Wei Qi Long Granules, Teng Xie Ning Granules, and Gan Ju Bing Mei Pian.
Related Articles

Capitalonline Data Service(300846.SZ): Tianyang Hongye intends to acquire 5.02% of the company's shares.

Chongqing Qin'an M&E PLC (603758.SH) intends to purchase a 99% stake in Yeguang Electronics in cash.

S.F. Holding (06936) controlling shareholder Mingde Holdings has transferred its holdings of 200 million A shares to the securities account of the employee stock ownership plan (A shares).
Capitalonline Data Service(300846.SZ): Tianyang Hongye intends to acquire 5.02% of the company's shares.

Chongqing Qin'an M&E PLC (603758.SH) intends to purchase a 99% stake in Yeguang Electronics in cash.

S.F. Holding (06936) controlling shareholder Mingde Holdings has transferred its holdings of 200 million A shares to the securities account of the employee stock ownership plan (A shares).

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025